MedPath

Effects of Home Based Exercise Therapy in Early Cirrhosis

Not Applicable
Completed
Conditions
Cirrhosis
Interventions
Behavioral: Home based Aerobic exercise training
Registration Number
NCT02267421
Lead Sponsor
University of Alberta
Brief Summary

Individuals with Cirrhosis have been shown to have a low aerobic capacity. While supervised exercise training has been shown to be an effective intervention to remedy this, there is currently no data on home based exercise interventions in this population. This study will evaluate the effects of a home based exercise program on the aerobic capacity of enrolled early stage liver cirrhosis patients, as well as changes in quality of life, thigh muscle thickness, and thigh muscle oxygen consumption.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age >18 and less than or equal to 70 years Liver Cirrhosis Child Pugh Class A or B If required, primary or secondary Variceal prophylaxis in place
Exclusion Criteria
  • Post-liver transplantation Hepatocellular carcinoma beyond transplant criteria Active non-hepatocellular carcinoma malignancy Significant cardiac disease Hemoglobin (<80 g/L) Oxygen saturation at rest <95% Known myopathy Chronic renal failure on dialysis Physical impairment making it impossible to ride an exercise bike or treadmill Orthopedic abnormality preventing exercise training HIV infection Patient unwilling to consent to study Child Pugh class C

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Home based aerobic exerciseHome based Aerobic exercise trainingHome based aerobic exercise on cycle ergometer. Three times per week, 30-60 minutes per session.
Primary Outcome Measures
NameTimeMethod
Change in peak exercise pulmonary oxygen uptake (VO2peak).Baseline (day 1) and Study End (8 weeks)
Secondary Outcome Measures
NameTimeMethod
Change in muscle mass as measured by thigh ultrasoundBaseline (day 1) and Study end (8 weeks)
Change in quality of life - Chronic Liver Disease QuestionnaireBaseline (Day 1) and Study completion (8 weeks)
Change in muscle oxygen extraction and consumption as measured by MRIBaseline (day 1) and study completion (8 weeks)

Trial Locations

Locations (1)

University of Alberta, Mazankowski Heart Institute

🇨🇦

Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath